Andrea van Elsas
2017
In 2017, Andrea van Elsas earned a total compensation of $1.8M as Chief Scientific Officer at Aduro BioTech.
Compensation breakdown
| Non-Equity Incentive Plan | $125,981 |
|---|---|
| Option Awards | $196,888 |
| Salary | $384,019 |
| Stock Awards | $1,051,529 |
| Total | $1,758,417 |
van Elsas received $1.1M in stock awards, accounting for 60% of the total pay in 2017.
van Elsas also received $126K in non-equity incentive plan, $196.9K in option awards and $384K in salary.
Rankings
In 2017, Andrea van Elsas' compensation ranked 6,147th out of 14,666 executives tracked by ExecPay. In other words, van Elsas earned more than 58.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,147 out of 14,666 | 58th |
Division Manufacturing | 2,258 out of 5,772 | 61st |
Major group Chemicals And Allied Products | 714 out of 2,075 | 66th |
Industry group Drugs | 551 out of 1,731 | 68th |
Industry Pharmaceutical Preparations | 433 out of 1,333 | 68th |
Source: SEC filing on April 20, 2018.
van Elsas' colleagues
We found two more compensation records of executives who worked with Andrea van Elsas at Aduro BioTech in 2017.